References:
1. Ghasemiyeh P, Mohammadi-Samani S.
COVID-19 outbreak: Challenges in pharmacotherapy based on
pharmacokinetic and pharmacodynamic aspects of drug therapy in patients
with moderate to severe infection. Heart & Lung. 2020.
2. Ghasemiyeh P, Borhani-Haghighi A,
Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, et al. Major
Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and
Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke:
A Narrative Review. Therapeutics and clinical risk management.
2020;16:595-605.
3. Ghasemiyeh P, Mohammadi-Samani S.
Iron Chelating Agents: Promising Supportive Therapies in Severe Cases of
COVID-19? Trends in Pharmaceutical Sciences. 2020;6(2):65-6.
4. NAWSHERWAN SK, Falak Z, Muhammad
SHOAIB GN, Ijaz U, Kang X, Hui L. Selected micronutrients: An option to
boost immunity against covid-19 and prevent adverse pregnancy outcomes
in pregnant women: A narrative review. Iranian Journal of Public Health.
2020;49(11):2032.
5. Espinola MSB, Bertelli M, Bizzarri
M, Unfer V, Laganà AS, Visconti B, et al. Inositol and vitamin D may
naturally protect human reproduction and women undergoing assisted
reproduction from Covid-19 risk. Journal of reproductive immunology.
2021:103271.
6. Anuk AT, Polat N, Akdas S, Erol SA,
Tanacan A, Biriken D, et al. The Relation Between Trace Element Status
(Zinc, Copper, Magnesium) and Clinical Outcomes in COVID-19 Infection
During Pregnancy. Biological trace element research. 2020:1-10.